Logo image of ACTD

ARCLIGHT CLEAN TRANSITION -A (ACTD) Stock Fundamental Analysis

USA - NASDAQ:ACTD - KYG0R21B1044 - Common Stock

7.6 USD
-0.22 (-2.81%)
Last: 7/21/2022, 8:00:00 PM
7.95 USD
+0.35 (+4.61%)
After Hours: 7/21/2022, 8:00:00 PM
Fundamental Rating

3

ACTD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. The financial health of ACTD is average, but there are quite some concerns on its profitability. ACTD has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ACTD has reported negative net income.
ACTD Yearly Net Income VS EBIT VS OCF VS FCFACTD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 -5M -10M -15M

1.2 Ratios

Industry RankSector Rank
ROA -3.84%
ROE N/A
ROIC -1.57%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ACTD Yearly ROA, ROE, ROICACTD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 -1 -2 -3 -4 -5

1.3 Margins

ACTD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACTD Yearly Profit, Operating, Gross MarginsACTD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACTD is destroying value.
ACTD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ACTD Yearly Shares OutstandingACTD Yearly Shares OutstandingYearly Shares Outstanding 2021 10M 20M 30M
ACTD Yearly Total Debt VS Total AssetsACTD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 100M 200M 300M

2.2 Solvency

ACTD has an Altman-Z score of 4.64. This indicates that ACTD is financially healthy and has little risk of bankruptcy at the moment.
ACTD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.64
ROIC/WACC-0.18
WACC8.71%
ACTD Yearly LT Debt VS Equity VS FCFACTD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 6.50 indicates that ACTD has no problem at all paying its short term obligations.
ACTD has a Quick Ratio of 6.50. This indicates that ACTD is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 6.5
Quick Ratio 6.5
ACTD Yearly Current Assets VS Current LiabilitesACTD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 500K 1M 1.5M

More info and screens

1

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1176.25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, ACTD will show a very strong growth in Earnings Per Share. The EPS will grow by 87.01% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y166.47%
EPS Next 2Y110.48%
EPS Next 3Y75.51%
EPS Next 5Y87.01%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACTD Yearly Revenue VS EstimatesACTD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 1B 2B 3B
ACTD Yearly EPS VS EstimatesACTD Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2 4 6 8 10

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

ACTD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 6.37, the valuation of ACTD can be described as very cheap.
When comparing the Price/Forward Earnings ratio of ACTD to the average of the S&P500 Index (22.50), we can say ACTD is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 6.37
ACTD Price Earnings VS Forward Price EarningsACTD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACTD Per share dataACTD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ACTD's earnings are expected to grow with 75.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y110.48%
EPS Next 3Y75.51%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ACTD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARCLIGHT CLEAN TRANSITION -A

NASDAQ:ACTD (7/21/2022, 8:00:00 PM)

After market: 7.95 +0.35 (+4.61%)

7.6

-0.22 (-2.81%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-16 2022-05-16/amc
Earnings (Next)N/A N/A
Inst Owners1.05%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap295.60M
Revenue(TTM)N/A
Net Income(TTM)-11990000
Analysts85.71
Price Target20.4 (168.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.37
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.07
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.28
EYN/A
EPS(NY)1.19
Fwd EY15.7%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS7.1
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.84%
ROE N/A
ROCE N/A
ROIC -1.57%
ROICexc N/A
ROICexgc -1.57%
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.5
Quick Ratio 6.5
Altman-Z 4.64
F-Score4
WACC8.71%
ROIC/WACC-0.18
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1176.25%
EPS Next Y166.47%
EPS Next 2Y110.48%
EPS Next 3Y75.51%
EPS Next 5Y87.01%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

ARCLIGHT CLEAN TRANSITION -A / ACTD FAQ

What is the ChartMill fundamental rating of ARCLIGHT CLEAN TRANSITION -A (ACTD) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ACTD.


Can you provide the valuation status for ARCLIGHT CLEAN TRANSITION -A?

ChartMill assigns a valuation rating of 5 / 10 to ARCLIGHT CLEAN TRANSITION -A (ACTD). This can be considered as Fairly Valued.


Can you provide the profitability details for ARCLIGHT CLEAN TRANSITION -A?

ARCLIGHT CLEAN TRANSITION -A (ACTD) has a profitability rating of 1 / 10.


How financially healthy is ARCLIGHT CLEAN TRANSITION -A?

The financial health rating of ARCLIGHT CLEAN TRANSITION -A (ACTD) is 4 / 10.